Insider Transactions in Q3 2023 at Neu Base Therapeutics, Inc. (NBSE)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2023
|
Symetryx Corp > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
50,000
-100.0%
|
$50,000
$1.19 P/Share
|
|
Sep 15
2023
|
Symetryx Corp > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
103,337
-67.39%
|
$103,337
$1.26 P/Share
|
|
Sep 14
2023
|
Symetryx Corp > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
129,108
-45.71%
|
$129,108
$1.44 P/Share
|
|
Sep 11
2023
|
Symetryx Corp > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
3,376
-0.71%
|
$3,376
$1.44 P/Share
|
|
Sep 08
2023
|
Symetryx Corp > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
128,847
-21.29%
|
$128,847
$1.53 P/Share
|
|
Sep 07
2023
|
Symetryx Corp > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
74,852
-11.01%
|
$74,852
$1.8 P/Share
|
|
Sep 01
2023
|
Symetryx Corp > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
61,076
+8.24%
|
$0
$0.98 P/Share
|
|
Aug 02
2023
|
Dietrich A Stephan Founder and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
93,234
+50.0%
|
$0
$0.02 P/Share
|